Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel HCV NS5A inhibitor shows proof of concept in nonhuman primates

March 28, 2012

First descriptions provided of BMS products now in phase II testing

March 27, 2012

Merck & Co. selects new agent for development in diabetes

March 27, 2012

New boron-based ROCK inhibitors show potential to treat inflammation and hypertension

March 27, 2012

U.S. study reveals new prognostic marker of aggressive kidney cancer

March 27, 2012

Promising data disclosed on apremilast in psoriasis and atopic dermatitis

March 27, 2012

New product extends therapeutic window of t-PA in stroke model

March 26, 2012

Toray evaluates 11-beta-HSD1 inhibitor in obesity and diabetes models

March 26, 2012

Durable submental fat reduction seen with ATX-101

March 26, 2012

New Wnt/catenin beta signaling inhibitor shows potential as cancer therapy

March 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...